Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial

[1] Lönnroth K(2015)Towards tuberculosis elimination: an action framework for low-incidence countries Eur Respir J 45 928-952

[2] Migliori GB(2016)The global burden of Latent tuberculosis infection: a re-estimation using mathematical Modelling PLoS Med 13 e1002152-e1002113

[3] Abubakar I(2013)Prospects for tuberculosis elimination Annu Rev Public Health 34 271-286

[4] D'Ambrosio L(2018)Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study Lancet Infect Dis 18 1-14

[5] de Vries G(2016)The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis The Lancet Infectious Diseases 16 1269-1278

[6] Diel R(2018)National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area Eur Respir J 51 1701226-595

[7] Douglas P(2013)SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials BMJ 346 e7586-1534

[8] Falzon D(2014)Accuracy of the medication adherence report scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD Ann Pharmacother 48 589-e45911

[9] Gaudreau M-A(2007)Educational outreach to promote screening for tuberculosis in primary care: a cluster randomised controlled trial Lancet (London, England) 369 1528-757

[10] Goletti D(2013)Point-of-care HIV testing in primary care and early detection of HIV (RHIVA2): a cluster randomised controlled trial Lancet 382 S7-413

[1] Lönnroth K(2015)Towards tuberculosis elimination: an action framework for low-incidence countries Eur Respir J 45 928-952

[2] Migliori GB(2016)The global burden of Latent tuberculosis infection: a re-estimation using mathematical Modelling PLoS Med 13 e1002152-e1002113

[3] Abubakar I(2013)Prospects for tuberculosis elimination Annu Rev Public Health 34 271-286

[4] D'Ambrosio L(2018)Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study Lancet Infect Dis 18 1-14

[5] de Vries G(2016)The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis The Lancet Infectious Diseases 16 1269-1278

[6] Diel R(2018)National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area Eur Respir J 51 1701226-595

[7] Douglas P(2013)SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials BMJ 346 e7586-1534

[8] Falzon D(2014)Accuracy of the medication adherence report scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD Ann Pharmacother 48 589-e45911

[9] Gaudreau M-A(2007)Educational outreach to promote screening for tuberculosis in primary care: a cluster randomised controlled trial Lancet (London, England) 369 1528-757

[10] Goletti D(2013)Point-of-care HIV testing in primary care and early detection of HIV (RHIVA2): a cluster randomised controlled trial Lancet 382 S7-413